Curaleaf Holdings Files October 2025 6-K Report

Ticker: CURLF · Form: 6-K · Filed: 2025-10-02T00:00:00.000Z

Sentiment: neutral

Topics: regulatory-filing, 6-K, press-release

TL;DR

Curaleaf filed its October 6-K, includes a press release, signed by legal chief.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on October 2, 2025, for the month of October 2025. The report indicates the company is a foreign private issuer and files annual reports under Form 40-F. The filing includes a press release as Exhibit 99.1. Peter Clateman, Chief Legal Officer, signed the report.

Why It Matters

This filing provides an update on Curaleaf's regulatory reporting status and includes a press release, which may contain material business developments.

Risk Assessment

Risk Level: low — This is a routine periodic filing (6-K) that primarily serves as a cover for other submitted documents like press releases.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have submitted or are required to submit to their home country's stock exchange.

Which form does Curaleaf Holdings, Inc. use for its annual reports?

Curaleaf Holdings, Inc. files annual reports under cover of Form 40-F.

Who signed the Form 6-K filing on behalf of Curaleaf Holdings, Inc.?

Peter Clateman, Chief Legal Officer, signed the report.

What is the filing date of this Form 6-K?

The filing date of this Form 6-K is October 2, 2025.

What is included as an exhibit in this filing?

Exhibit 99.1, a Press Release, is included in this filing.

From the Filing

0001756770-25-000034.txt : 20251002 0001756770-25-000034.hdr.sgml : 20251002 20251002170222 ACCESSION NUMBER: 0001756770-25-000034 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20251001 FILED AS OF DATE: 20251002 DATE AS OF CHANGE: 20251002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 251370439 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover100125announcemen.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: October 2, 2025 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release EX-99.1 2 a2025-10x01xcuraleafxann.htm EX-99.1 a2025-10x01xcuraleafxann Curaleaf Holdings, Inc. Investor Relations Curaleaf Announces Executive Automatic Securities Disposition Plan STAMFORD, Conn., Oct. 1, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that effective as of September 30, 2025, Mr. Joseph F. Lusardi, the Company's Executive Vice Chairman, has established an automatic securities disposition plan ("ASDP") in accordance with applicable United States and Canadian securities legislation and the Company's trading policies. The ASDP will allow for an orderly exercise of options set to expire in March 2026, and the sale of a portion of the acquired subordinate voting shares in the Company (the "Subordinate Voting Shares") currently owned by Mr. Lusardi to cover anticipated taxes. The Subordinate Voting Shares will be sold at prevailing market prices, and sales may commence on January 2, 2026 and continue over the course of a three-month period. Under United States and Canadian securities laws and the Company's trading policies, insiders of Curaleaf are subject to limits on their ability to sell shares in the Company. ASDPs address this issue by permitting trades to be made in accordance with pre- arranged instructions given when executives are not in possession of any material undisclosed information. Canadian securities laws permit insiders to adopt ASDPs to sell, donate or otherwise transfer shares in the future in accordance with the pre- arranged terms of their ASDP, on an automatic basis, regardless of any subsequent material non-public information they receive. Once an ASDP is established, the insider is not permitted to exercise any further discretion or influence over how dispositions will occur under the ASDP. Sales of Subordinate Voting Shares under the ASDP will be e

View on Read The Filing